ATLASIGC Pharma (IGC) earnings date: Nov 13, 2026
IGC Pharma (IGC) reports earnings for the quarter ended Sep 30, 2026 on Fri, Nov 13, 2026. Analysts expect EPS of -$0.02.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on IGC
| Last price | $0.19 (+0.9%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.8% |
| Earnings beat history | Beat the EPS estimate in 1 of the last 5 reports |
These figures come from the same calibrated model and valuation as the IGC Pharma stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
IGC Pharma reports on Nov 13, 2026. One email the day before, with ATLAS’s read on IGC Pharma. You can switch it off at any time.
Alert me before IGC reportsFree to start. Creating an account takes under a minute.
Notify me when IGC Pharma reports
Track IGC free Add IGC Pharma to a free ATLAS watchlist and see its next report date in one place.
IGC earnings at a glance
| Next report (confirmed) | Fri, Nov 13, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.02 |
| Last report | Aug 14, 2026 · Miss |
| Beat rate (last 5 reports) | 1 of 5 (20%) |
| Average EPS surprise | -1.8% |
| Average move around a report | ±4.6% (last 5) |
| Sector | Healthcare · Biotechnology |
IGC Pharma earnings history: last 5 reports
IGC Pharma last reported on Aug 14, 2026: EPS of -$0.03 against an estimate of -$0.02 (-50.0% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 14, 2026 | -$0.02 | -$0.03 | -50.0% | Miss | -3.5% |
| May 15, 2026 | -$0.02 | -$0.02 | 0.0% | In line | -3.3% |
| Apr 24, 2026 | $1.56 | $1.59 | +1.9% | In line | -5.9% |
| Nov 14, 2025 | -$0.02 | -$0.02 | 0.0% | In line | -5.6% |
| Sep 29, 2025 | -$0.18 | -$0.11 | +38.9% | Beat | +5.0% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for IGC
See the fair value, the probability range and the earnings history of IGC Pharma on its ATLAS page.
IGC Pharma (IGC) stock analysisPlans from €3.99 a month.
IGC Pharma earnings: frequently asked questions
When does IGC Pharma (IGC) report earnings?
IGC Pharma is scheduled to report on Friday, November 13, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for IGC?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.02 per share (USD). Estimates can change before the report.
How often does IGC beat earnings estimates?
Of its last 5 reports with a recorded result, IGC Pharma beat the EPS estimate 1 times; the average surprise was -1.8%. Past results do not predict the next one.
How much does IGC move around earnings?
Over its last 5 reports the stock moved an average of 4.6% (absolute, from the close before the report day to the close after it), and finished higher 1 of 5 times.
Did IGC Pharma beat earnings estimates last quarter?
IGC Pharma last reported on Aug 14, 2026: EPS of -$0.03 against an estimate of -$0.02 (-50.0% surprise), a miss.
How much does IGC usually move in a day?
On a normal trading day the ATLAS model puts IGC’s one-day range at about ±4.8%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Fri, Nov 13, 2026
Educational information, not investment advice. Disclaimer